News About: Distribution
Myungsung taking over Jeongdo's credits and debts.
As of the date of May 23, Myungsung will take over all credits and debts of Jeongdo.
Myungsung acquired Jeongdo as an amicable M&A on May 20, taking over all credits and debts of Jeongdo according to the agreement...
Myungsung-Jeongdo M&A surfaced to top wholesaler.
A giant OTC drug wholesaler was born in the metropolitan area. Myungsung and Jeongdo have agreed to merge on May 20.
The M&A was made by Myungsung's acquisition of Jeongdo but its detailed terms and conditions have...
Wholesaler's expenses for returned stocks to be compensated.
The Korea Pharmaceutical Association forwarded a letter of certified contents to the Korea Pharmaceutical Wholesale Association, asking for the returned stocks but the KPWA responded in a feeling of unsatisfaction tha...
12% market shares by 89% of minor drug wholesalers.
Number of minor drug wholesalers selling less than 10 billion won a year showed ever increasing trends to occupy by almost 90% of the total drug wholesalers but in contrast, their market shares stood almost negligible...
Cooperation between Zuellig and Wholesalers to stay talking only.
Most of domestic drug wholesalers are in deep complains over the Zuellig's policy of the distribution margins, which was individually established with different wholesalers at different rates.
Zuellig has slashed t...
Zuellig to strike on the back of drug wholesalers heads.
Zuellig has established their distribution marin policies by different rates as 8% for the monthly sales over 1.5 billion won (basic 5% plus 1.5% for the payment in 30 days and 1.5% more per year), 7% for more than 1 ...
Wholesalers adopting 2nd phase for generic drug promotion.
The KPWA's Hospital Committee meeting under the title of "the generic drug sales promotion review" at Tower hotel on May 10T has made the local wholesaler's campaign for the sales promotion of generic drugs enter into...
Pricing standards for combined and modified new drugs in urgent need.
To foster the R&D of a modified new drug that was suggested as one of the future drug industrial development issues, it is urgently required for the drug pricing account standards especially of the combined and modifi...
KPMA to urge removal of public advertising ban on OTC drugs.
The Korea Pharmaceutical Manufacturers Association (KPMA: chairman: Kim Jeong-soo) urged to the Korea Broadcasting Commission (KBC) that the public advertising ban on 12 therapeutic drug groups including drugs for liv...
Local Wholesale Distributors Continue Experience Significant Profit Erosion
The financial performance results as reported by the major pharmaceutical wholesale distributors in the nation suggest that they collectively experience erosion in the bottom-line profitability, in spite of a moderate...
